Is Caenorhabditis elegans the Magic Bullet for Anthelminthic Drug Discovery?

Trends in Parasitology

Volumn 31, Issue 10, 2015, Pages 455-456

  Keiser, Jennifer ^a,b  

^a SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Anthelminthics; Caenorhabditis elegans; Drug discovery

Indexed keywords

ALBENDAZOLE; ANTHELMINTIC AGENT; BENZIMIDAZOLE DERIVATIVE; IVERMECTIN; LEVAMISOLE; MEBENDAZOLE; MONEPANTEL;

ANCYLOSTOMA CEYLANICUM; ANIMAL HEALTH; ASCARIS LUMBRICOIDES; CAENORHABDITIS ELEGANS; COOPERIA; DRUG EFFECT; DRUG IDENTIFICATION; DRUG SENSITIVITY; DRUG TARGETING; GENETIC MODEL; HAEMONCHUS CONTORTUS; HATCHING; HELIGMOSOMOIDES; HIGH THROUGHPUT SCREENING; HUMAN; IN VITRO STUDY; LARVAL DEVELOPMENT; LARVAL STAGE; MEDLINE; NECATOR AMERICANUS; NEMATODIASIS; NONHUMAN; SCREENING TEST; SHORT SURVEY; TRICHURIS MURIS; TRICHURIS TRICHIURA; VETERINARY MEDICINE; ANIMAL; DRUG DEVELOPMENT; DRUG EFFECTS; DRUG SCREENING; PROCEDURES;

ANIMALS; ANTHELMINTICS; CAENORHABDITIS ELEGANS; DRUG DISCOVERY; DRUG EVALUATION, PRECLINICAL; PARASITIC SENSITIVITY TESTS;

EID: 84943259243     PISSN: 14714922     EISSN: 14715007     Source Type: Journal    
DOI: 10.1016/j.pt.2015.08.004     Document Type: Short Survey

References (10)

1. Murray C.J., et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012, 380:2197-2223.
2. Keiser J., et al. The drugs we have and the drugs we need against major helminth infections. Adv. Parasitol. 2010, 73:197-230.
3. Silbereisen A., et al. Exploration of novel in vitro assays to study drugs against Trichuris spp. J. Microbiol. Methods 2010, 73:169-175.
4. Simpkin K.G., et al. The use of Caenorhabditis elegans for anthelmintic screening. J. Chem. Tech. Biotechnol. 1981, 31:66-69.
5. O'Reilly L.P., et al. C. elegans in high-throughput drug discovery. Adv. Drug Deliv. Rev. 2014, 69-70:247-253.
6. Burns A.R., et al. Caenorhabditis elegans is a useful model for anthelmintic discovery. Nat. Commun. 2015, 6:7485.
7. Hu Y., et al. An extensive comparison of the effect of anthelmintic classes on diverse nematodes. PLoS ONE 2013, 8:e70702.
8. Geary T.G., et al. Frontiers in anthelmintic pharmacology. Vet. Parasitol. 1999, 84:275-295.
9. Tritten L., et al. In vitro and in vivo efficacy of monepantel (AAD 1566) against laboratory models of human intestinal nematode infections. PLoS Negl. Trop. Dis. 2011, 5:e1457.
10. Tritten L., et al. In vitro and in vivo efficacy of tribendimidine and its metabolites alone and in combination against the hookworms Heligmosomoides bakeri and Ancylostoma ceylanicum. Acta Trop. 2012, 122:101-107.